Siemensma EP, de Lind van Wijngaarden RF, Otten BJ, de Jong FH, Hokken-Koelega AC
The Bottom Line GLP-1 agonists are powerful and effective medications for Type 2 diabetes and obesity
The second trial included a broader array of antipsychotics, but liraglutide only showed nonsignificant trends toward lower weight and HbA1c, possibly because of a small sample size (47) (Whicher CA et al, Diabetes Obes Metab 2021;23(6):12621271)
Many people describe the drugs effects not simply as appetite suppression, but as a quieting of persistent food noise. But as clinical trials expand and preclinical research continues, evidence is accumulating that these medications exert much broader physiological effects than previously thought
Noom CEO Saeju Jeong said the goal is to help patients avoid chronic illness, increase their lifespan and enhance their ability to enjoy their lives through weight loss, according to a Wednesday news release
Special Note About Pediatric Language You May See Online Some online text mentions pediatric weight programs and activity requirements